SCHEMBL6793043

SCHEMBL6793043

O=CN(CCc1ccccn1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CRHBP P24387 1/20 0.44
ATM Q13315 1/20 0.44
CRHR2 Q13324 1/20 0.44
TLR9 Q9NR96 1/20 0.44
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
TSHR P16473 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227384 0.83 CYP1A2 (0.49) POLBALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL6795581 0.82 POLB (0.73) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6503514 0.81 HRH1 (0.47) POLBL3MBTL1CYP1A2CYP3A4TSHR
SCHEMBL6227307 0.81 NPSR1 (0.55) POLBL3MBTL1CYP1A2CYP3A4TSHR
SCHEMBL6792835 0.81 POLB (0.53) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6252749 0.81 POLB (0.50) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6793045 0.81 CCNC (0.41) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL27600739 0.80 POLB (0.56) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6226630 0.78 NPC1 (0.50) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6798819 0.78 POLB (0.57) POLBKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 POLB 1470/4885KMT2A 2457/4885MEN1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.